Viewing Study NCT06440343



Ignite Creation Date: 2024-06-16 @ 11:51 AM
Last Modification Date: 2024-10-26 @ 3:31 PM
Study NCT ID: NCT06440343
Status: COMPLETED
Last Update Posted: 2024-06-10
First Post: 2024-05-21

Brief Title: Effects of Acute Carbohydrate Intake Intra-training in Crosstraining
Sponsor: Universidad de Granada
Organization: Universidad de Granada

Study Overview

Official Title: Effects of Acute Carbohydrate Intake Intra-training in Crosstraining Athletes a Randomized Placebo-controlled Crossover Study
Status: COMPLETED
Status Verified Date: 2024-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study aims to investigate the effect of acute carbohydrate intake during a crosstraining session on exercise-induced muscle damage and the recovery of crosstraining athletes
Detailed Description: Carbohydrate intake during exercise could decrease the subjective perceived exertion and promote recovery during high-intensity and intermittent exercises such as crosstraining Nevertheless despite extensive research on carbohydrate ingestion during exercise across different sports disciplines its effects have not been investigated in crosstraining sessions

23 male trained crosstraining athletes will ingest carbohydrates 60g of maltodextrin fructose 21 ratio or placebo during a one-and-a-half-hour crosstraining session The session will consist of a warm-up a weightlifting part a strength part a WOD and an AMRAP The rating of perceived exertion RPE will be assessed using the validated Borg scale at the beginning of the session after each part of the training and at the end of the session DOMS will be assessed using a visual analog scale at 24 and 48 hours after the crosstraining session

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None